Search Products:

Enter Catalogue #, CAS # , Chemical Name or Mol Formula:
  • A108502
    Abiraterone Acetate-d4
    [154229-18-2] unlabelled
    C₂₆H₂₉D₄NO₂
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate-d4 (Ester); CB 7630-d4;
  • A108505
    Abiraterone Tosylate
    C₃₁H₃₇NO₃S
  • A108510
    Abiraterone Acetate N-Oxide
    C₂₆H₃₃NO₃
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate (Ester) N-Oxide; CB 7630 N-Oxide;
  • A108515
    Abiraterone Sulfate Sodium Salt
    Parent Compound: 154229-19-3
    C₂₄H₃₀NNaO₄S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Sulfate Sodium;
  • A108517
    Abiraterone Sulfate Sodium Salt-D4
    C₂₄H₂₆D₄NNaO₄S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Sulfate Sodium-D4;
  • A108520
    Abiraterone N-Oxide Sulfate Sodium Salt
    Free Acid: 1993430-24-2; Parent Compound: 154229-1
    C₂₄H₃₀NNaO₅S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol N-Oxide Sulfate Sodium Salt;
  • A108522
    Abiraterone N-Oxide Sulfate Sodium Salt-D4
    C₂₄H₂₆D₄NNaO₅S
    (3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol N-Oxide Sulfate Sodium Salt-D4;
  • A108525
    Abiraterone Ethyl Ether
    C₂₆H₃₅NO
    3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108527
    Abiraterone Ethyl Ether-d5
    Unlabelled CAS# N/A
    C₂₆H₃₀D₅NO
    3-((3S,8R,9S,10R,13S,14S)-3-ethoxy--d5-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108530
    Abiraterone Isopropyl Ether
    C₂₇H₃₇NO
    3-((3S,8R,9S,10R,13S,14S)-3-Isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108532
    Abiraterone Isopropyl Ether-d7
    Unlabelled CAS# N/A
    C₂₇H₃₀D₇NO
    3-((3S,8R,9S,10R,13S,14S)-3-Isopropoxy-d7-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
  • A108535
    Abiaterone-5,6-epoxide
    C₂₄H₃₃NO₂
    5,6-Epoxy Abiaterone
  • A108540
    Abiraterone N-Oxide
    C₂₄H₃₁NO₂
  • A108545
    (3β)-16-[(3β)-3-Hydroxyandrosta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
    186826-70-0
    C₄₃H₅₇NO₂
  • A108550
    (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
    186826-68-6
    C₄₇H₆₁NO₄
    (3β)-16-[(3β)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol Acetate (ester)
  • A108555
    3,5-cyclo-Abiraterone
    C₂₄H₃₁NO
  • A108910
    Abnormal Cannabidiol
    22972-55-0
    C₂₁H₃₀O₂
    4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; CAY10429; trans-(-)-4-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; trans-(-)-4-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; Abn-CBD
  • A108912
    Abnormal Cannabidiol-d9
    Unlabelled: 22972-55-0
    C₂₁H₂₁D₉O₂
    4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9; CAY10429; trans-(-)-4-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol-d9; trans-(-)-4-[3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol-d9
  • A108980
    ---
    ---
    ---
    ---
    ---
    This is a controlled substance:Pending Status
  • A109000
    ---
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A109002
    AB-PINACA-d9
    1445752-09-9 unlabelled
    C₁₈H₁₇D₉N₄O₂
    (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(pentyl-2,2’,3,3’,4,4’,5,5,5-d9)-1H-indazole-3-carboxamide
  • A109005
    ---
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A109010
    ---
    ---
    ---
    ---
    ---
    This is a controlled substance:Controlled Substance Sch II
  • A109045
    Abridin
    73030-56-5
    C₂₅H₃₆O₂
    (22E)-26,27-Dinorcholesta-4,22-diene-3,24-dione;
  • A109070
    L-Abrine
    526-31-8
    C₁₂H₁₄N₂O₂
    N-Methyl-L-tryptophan; (S)-3-(1H-Indol-3-yl)-2-methylaminopropionic Acid; Abrine; Abrine (amino acid); L-(+)-Abrine; L-Abrine; L-N-Methyltryptophan; N-Methyltryptophan; N-α-Methyl-L-tryptophan; NPLC 0233;
  • A109095
    Abscisic Acid Methyl Ester
    60102-39-8
    C₁₆H₂₂O₄
    (+)-Methyl Abscisate; (S)-Abscisic Acid Methyl Ester; 5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester
  • A110000
    (+)-cis,trans-Abscisic Acid, 98%
    21293-29-8
    C₁₅H₂₀O₄
    (S-(Z,E)])-5-(1-Hydroxy-2,6,6-trimethyl)-4-oxo-2-cyclohexen-1-yl-3-methyl-2,4-pentadienoic Acid; (+)-(S)-Abscisic Acid; (+)-(cis,trans)-Abscisic Acid; (+)-ABA; S-ABA; Dormin;
  • A110002
    (+)-cis,trans-Abscisic Acid-d6
    721948-65-8
    unlabelled: 21293-29-8
    C₁₅H₁₄D₆O₄
    [S-(Z,E)]-5-[1-Hydroxy-6,6-dimethyl-2-(methyl-d6)-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid; S-ABA-d6; Dormin-d6;
  • A110003
    (+)-cis,trans-Abscisic Acid-d6
    35671-08-0
    Unlabelled: 21293-29-8
    C₁₅H₁₄D₆O₄
    (R-(Z,E)])-5-(1-Hydroxy-2,6,6-trimethyl)-4-oxo-2-cyclohexen-1-yl-3-methyl-2,4-pentadienoic Acid-d6; (+)-(R)-Abscisic Acid-d6; (+)-(cis,trans)-Abscisic Acid-d6; (+)-ABA-d6; R-ABA-d6; Dormin-d6;
  • A110004
    (+)-cis,trans-Abscisic Acid
    14398-53-9
    C₁₅H₂₀O₄
    (2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid; (-)-(R)-Abscisic Acid; (-)-(cis,trans)-Abscisic Acid; (-)-ABA; (-)-Abscisic Acid; (R)-(-)-Abscisic Acid; (R)-Abscisic Acid; PBI 145
  • A110005
    (+)-Abscisic Aldehyde
    41944-86-9
    C₁₅H₂₀O₃
    (2Z,4E)-5-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienal; (+)-Abscisyl aldehyde; Abscisic Aldehyde
  • A110010
    rac 8’-Acetylene Abscisic Acid Methyl Ester
    192987-96-5
    C₁₇H₂₀O₄
    (2Z,4E)-rel-5-[(1R,6R)-6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid Methyl Ester; PBI 429;
  • A110015
    (±)-Abscisic Aldehyde
    29448-38-2
    C₁₅H₂₀O₃
    (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4- pentadienal; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)- 3-methyl-2,4-pentadienal; PBI 37
  • A110017
    (±)-Abscisic Aldehyde-d3
    Unlabelled: 29448-38-2
    C₁₅H₁₇D₃O₃
    (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4- pentadienal-d3; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)- 3-methyl-2,4-pentadienal-d3; PBI 37-d3;
  • A110025
    (+)-trans,trans-Abscisic Acid
    6755-41-5
    C₁₅H₂₀O₄
    (2E,4E)-5-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic Acid; (+)-trans-Abscisic Acid; (E,E)-Abscisic Acid; 2-trans,4-trans-Abscisic Acid; E,E-(+)-Abscisic Acid; trans-trans-(+)-Abscisic Acid; S-ttABA; [S-(E,E)]-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid; (E,E)-(S)-(+)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid; (2E,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid
  • A110030
    (±)-cis,trans-Abscisic Acid Methyl Ester
    6901-96-8
    C₁₆H₂₂O₄
    ABAMe; (±)-Abscisic Acid Methyl Ester; (±)-Methyl Abscisate; (±)-cis-Abscisin Methyl Ester; Methyl Abscisate; PBI 0; (Z,E)-(±)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester; (Z,E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester; (2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic Acid Methyl Ester
  • A110035
    (±)-cis,trans-Abscisic Acid Glucosyl Ester Discontinued- Please see A110125
    79199-48-7
    C₂₁H₃₀O₉
    ABAGlc; (Z,E)-1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; (±)-Abscisic Acid Glucose Ester; (Z,E)-(±)-1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; 1-[(2Z,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose
  • A110040
    (±)-cis,trans-Abscisic Acid-ß-D-glucopyranosyl Ester Tetraacetate
    79199-47-6
    C₂₉H₃₈O₁₃
    (Z,E)-(±)-2,3,4,6-Tetraacetate 1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; (Z,E)-2,3,4,6-Tetraacetate 1-[5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate] β-D-Glucopyranose; ABAGlcTAc
  • A110045
    (+)-cis,trans-Abscisic Acid-L-glutamic Acid
    1285592-12-2
    C₂₀H₂₇NO₇
    ABA-L-Glu; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-glutamic Acid; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-glutamic Acid
  • A110050
    (+)-cis,trans-Abscisic Acid-L-phenylalanine
    1285591-91-4
    C₂₄H₂₉NO₅
    N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-phenylalanine; ABA-L-Phe; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-phenylalanine
  • A110055
    (+)-cis,trans-Abscisic Acid-L-tryptophan
    1285591-94-7
    C₂₆H₃₀N₂O₅
    ABA-L-Trp; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-tryptophan; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-tryptophan
  • A110060
    (+)-cis,trans-Abscisic Acid-glycine
    1285591-89-0
    C₂₀H₂₉NO₅S
    ABA-Gly; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-methionine
  • A110065
    (+)-cis,trans-Abscisic Acid-L-alanine
    1285591-80-1
    C₁₈H₂₅NO₅
    N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-alanine; ABA-L-Ala; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-alanine
  • A110070
    (+)-cis,trans-Abscisic Acid-L-valine
    1285591-82-3
    C₂₀H₂₉NO₅
    ABA-L-Val; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-valine; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-valine
  • A110075
    (+)-cis,trans-Abscisic Acid-L-leucine
    1285591-85-6
    C₂₁H₃₁NO₅
    N-[(2Z,4E)-5-[(1R)-1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-leucine; ABA-L-Leu
  • A110080
    (+)-cis,trans-Abscisic Acid-L-isoleucine
    1285591-88-9
    C₂₁H₃₁NO₅
    ABA-L-Ile; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-isoleucine
  • A110085
    (+)-cis,trans-Abscisic Acid-L-aspartic Acid
    1285592-10-0
    C₁₉H₂₅NO₇
    N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-aspartic Acid; ABA-L-Asp
  • A110090
    (+)-cis,trans-Abscisic Acid-L-proline
    1285591-90-3
    C₂₀H₂₇NO₅
    1-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-proline; ABA-L-Pro
  • A110095
    (+)-cis,trans-Abscisic Acid-L-tyrosine
    1285592-04-2
    C₂₄H₂₉NO₆
    ABA-L-Tyr; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-tyrosine; N-[(2Z,4E)-5-[(1R)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-1-oxo-2,4-pentadien-1-yl]-L-tyrosine
  • A110098
    (+)-trans,trans-Abscisic Acid-d3
    82298-40-6
    Unlabelled: 6755-41-5
    C₁₅H₁₇D₃O₄
    [S-(E,E)]-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-(methyl-d3)-2,4-pentadienoic Acid
  • A110125
    (S)-cis,trans-Abscisic Acid Glucosyl Ester
    21414-42-6
    C₂₁H₃₀O₉
    β-D-1-[(Z,E)-(+)-5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoate]glucopyranose; (+)-Abscisic acid glucose ester; (+)-Abscisyl-β-D-glucopyranoside
  • A110150
    ABL127
    1073529-41-5
    C₁₇H₂₀N₂O₅
    (3R)-3-cyclopentyl-4-oxo-3-phenyl-1,2-Diazetidine-1,2-dicarboxylic Acid 1,2-Dimethyl Ester;
  • A111000
    α-Amylcinnamaldehyde
    122-40-7
    C₁₄H₁₈O
    Cinnamaldehyde, alpha-amyl- (4Cl); Cinnamaldehyde, alpha-pentyl-(6Cl, 7Cl, 8Cl); 2-(Phenylmethylene)heptanal; 2-Benzylideneheptanal; Amyl Cinnamal; Amylcinnamaldehyde; Amylcinnami acid aldehyde; Amylcinnamic aldehyde; Flominel Jasminal; Jasminaldehyde; jasmine aldehyde; NSC 6649; Pentylcinnamaldehyde; alpha-Amyl-beta-phenylacrolein; alpha-Amylcinnamal; alpha-Amylcinnamaldehyde; alpha-Pentylcinnamaldehyde
  • A111600
    Absinthin
    1362-42-1
    C₃₀H₄₀O₆
    (3S,3aS,6S,6aR,6bS,7S,7aR,8S,10aS,11S,13aS,13bR,13cR,14bS)-3,3a,4,5,6,6a,6b,7,7a,8,9,10,10a,13a,13c,14b-Hexadecahydro-6,8-dihydroxy-3,6,8,11,14,15-hexamethyl-2H-7,13b-Ethenopentaleno[1’’,2’’:6,7;5’’,4’’:6’,7’]dicyclohepta[1,2-b:1’,2’-b’]difuran-2,12(11H)-dione; [3S-(3α,3aα,6β,6aα,6bβ,7α,7aβ,8α,10aβ,11β,13aα,13bα,13cβ,14bβ)]-3,3a,4,5,6,6a,6b,7,7a,8,9,10,10a,13a,13c,14b-Hexadecahydro-6,8-dihydroxy-3,6,8,11,14,15-hexamethyl-2H-7,13b-Ethenopentaleno[1’’,2’’:6,7;5’’,4’’:6’,7’]dicyclohepta[1,2-b:1’,2’-b’]difuran-2,12(11H)-dione; Absinthin; NSC 407315
  • A112425
    ABT 199 (>99%) (Venetoclax)
    1257044-40-8
    C₄₅H₅₀ClN₇O₇S
    4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
  • A112430
    ABT 199 (Venetoclax)
    1257044-40-8
    C₄₅H₅₀ClN₇O₇S
    4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide; Venetoclax
  • A112432
    ABT-199-D10
    Unlabelled: 1257044-40-8
    C₄₅H₄₀D₁₀ClN₇O₇S
    Venetoclax-d10
  • A112435
    ABT 702 Dihydrochloride
    1188890-28-9
    Free Base: 214697-26-4
    C₂₂H₁₉N₆OBr • 2(HCl)
    5-(3-Bromophenyl)-7-[6-(4-morpholinyl)-3-pyrido[2,3-d]byrimidin-4-amine dihydrochloride
  • A112500
    ABT 263
    923564-51-6
    C₄₇H₅₅ClF₃N₅O₆S₃
    4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide; Navitoclax
  • A112502
    ABT 263-d8
    1217620-38-6
    unlabelled: 923564-51-6
    C₄₇H₄₇D₈ClF₃N₅O₆S₃
    4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide-d8;
  • A112510
    ABT-639 Hydrochloride
    1235560-31-2
    Free Base: 1235560-28-7
    C₂₀H₂₀ClF₂N₃O₃S • HCi
    4-Chloro-2-fluoro-N-(2-fluorophenyl)-5-[[(8aR)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]carbonyl]-, Benzenesulfonamide Hydrochloride
  • A112550
    ABT 737
    852808-04-9
    C₄₂H₄₅ClN₆O₅S₂
    4-[4-[(4’-Chloro[1,1’-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide;
  • A112552
    ABT 737-d8
    1217686-68-4
    unlabelled: 852808-04-9
    C₄₂H₃₇D₈ClN₆O₅S₂
    4-[4-[(4’-Chloro[1,1’-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide-d8;
  • A112580
    ABT 888
    912444-00-9
    C₁₃H₁₆N₄O
    2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide; A 861695;
  • A112600
    ABT 925 Fumerate
    220519-07-3
    C₂₄H₃₁F₃N₆O₅S
    2-[[3-[4-[2-(1,1-Dimethylethyl)-6-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinyl]propyl]thio]-4(1H)-pyrimidinone (2E)-2-Butenedioate
  • A112602
    ABT 925-d6 Fumerate
    220519-07-3 unlabelled
    C₂₄H₂₅D₆F₃N₆O₅S
    2-[[3-[4-[2-(1,1-Dimethylethyl)-6-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinyl]propyl]thio]-4(1H)-pyrimidinone-d6 (2E)-2-Butenedioate
  • A112603
    A54556B
    95398-44-0
    C₃₇H₄₈N₆O₈
    A 54556 factor B; A 54556B; Antibiotic A 54556B;
  • A112605
    ABT 724 Trihydrochloride
    Free Base: 70006-24-5
    C₁₇H₁₉N₅
    2-[[4-(2-Pyridinyl)-1-piperazinyl]methyl]-1H-benzimidazole; 2-[[4-(Pyridin-2-yl)piperazin-1-yl]methyl]-1H-benzimidazole; ABT 724;
  • A112608
    I-AB-MECA
    152918-27-9
    C₁₈H₂₀IN₇O₄
    N6-(4-Amino-3-iodobenzyl)adenosine-5’-(N-methyluronamide); AB-MECA; 1-[6-[[(4-Amino-3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide;
  • A112610
    ABT-418 Hydrochloride
    147388-83-8
    Free Base: 147402-53-7
    C₉H₁₄N₂O •HCl
    3-Methyl-5-(1-methyl-2(S)-pyrrolidinyl)isoxazole Hydrochloride;
  • A112613
    AB-MECA
    152918-26-8
    C₁₈H₂₁N₇O₄
    1-[6-[[(4-Aminophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide;
  • A112615
    ABO Dihydrochloride
    Free Base: 896126-03-7
    C₉H₁₂N₂O₂ • 2HCl
    6-Amino-2,3-dihydro-3-hydroxymethyl-1,4-benzoxazine dihydrochloride; 6-Amino-3,4-dihydro-2H-1,4-benzoxazine-3-methanol;
  • A112618
    ABT 724 Trihydrochloride
    587870-77-7
    Free Base: 70006-24-5
    C₁₇H₁₉N₅ • 3(HCl)
    2-[[4-(2-Pyridinyl)-1-piperazinyl]methyl]-1H-benzimidazole trihydrochloride
  • A112620
    ABT 751
    141430-65-1
    C₁₈H₁₇N₃O₄S
    N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide; ABT 51; ABT 751; E 7010; E 7010 (Pharmaceutical); N-[2-[(4-Hydroxyphenyl)amino]-3-pyridyl]-4-methoxybenzenesulfonamide
  • A112623
    Aberchrome 670
    94856-25-4
    C₂₂H₂₄O₄
  • A112625
    ABZ-GLY-OH Hydrochloride
    256657-23-5
    C₉H₁₀N₂O₃ • HCl
  • A112648
    AB-FUBINACA Isomer 5
    C₂₀H₂₁FN₄O₂
    N-(1-Amino-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-N-methyl-1H-indazole-3-carboxamide
  • A112650
    ABT 594 Hydrochloride
    203564-54-9
    198283-73-7
    C₉H₁₁ClN₂O • (HCl)
    (R)-5-(Azetidin-2-ylmethoxy)-2-chloropyridine Hydrochloride; Tebanicline
  • A112653
    ---
    ---
    ---
    ---
    ---
    This is a controlled substance:Next for Status
  • A115000
    AC 220
    950769-58-1
    C₂₉H₃₂N₆O₄S
    AC 010220; Quizartinib; N-(5-tert-Butylisoxazol-3-yl)-N’-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea;
  • A115150
    Z-3-Abz-osu
    129666-48-4
    C₁₉H₁₆N₂O₆
    [3-[[(2,5-Dioxo-1-pyrrolidinyl)oxy]carbonyl]phenyl]-carbamic Acid Phenylmethyl Ester;
  • A115153
    Abemaciclib
    1231929-97-7
    C₂₇H₃₂F₂N₈
    N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine; LY 2835219; N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine
  • A115155
    AbK
    1253643-88-7
    C₁₁H₂₀N₄O₄.CF₃CO₂H
    N6-[[2-(3-Methyl-3H-diazirin-3-yl)ethoxy]carbonyl]-L-lysine
  • A115600
    AC 42
    447407-36-5
    C₂₀H₃₂ClNO
    4-(4-Butyl-1-piperidinyl)-1-(2-methylphenyl)-1-butanone Hydrochloride; AC 42 (pharmaceutical);
  • A115605
    Acalabrutinib
    1420477-60-6
    C₂₆H₂₃N₇O₂
    4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; ACP 196
  • A115615
    Ac-d-alpha-indanylglycine
    179185-77-4
    C₁₃H₁₅NO₃
  • A115650
    ACP-105
    899821-23-9
    C₁₆H₁₉ClN₂O
    2-Chloro-4-[(3-endo)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1]oct-8-yl]-3-methylbenzonitrile;
  • A115653
    cis-ACPD
    39026-63-6
    C₇H₁₁NO₄
    (1R,3R)-1-Aminocyclopentane-1,3-dicarboxylic Acid; 1,3-Cyclopentanedicarboxylic Acid
  • A115655
    cis-1,3-homo-ACPD
    194785-82-5
    C₈H₁₃NO₄
    (1S-trans)-3-Amino-3-carboxy-cyclopentaneacetic Acid;
  • A115658
    (1R,3S)-homo-ACPD
    194785-80-3
    C₈H₁₃NO₄
  • A115660
    (1S,3S)-homo-ACPD
    194785-78-9
    C₈H₁₃NO₄
  • A115663
    trans-(1S,3R)-ACPD
    111900-32-4
    C₇H₁₁NO₄
  • A115665
    ACPT-I
    194918-76-8
    C₈H₁₁NO₆
    (1S,3R,4S)-1-Aminocyclopentane-1,3,4-tricarboxylic Acid; (1α,2α,4β)-4-Amino-1,2,4-cyclopentanetricarboxylic Acid
  • A115668
    ACPT-II
    195209-04-2
    C₈H₁₁NO₆
    (1R,3R,4S)-1-Aminocyclopentane-1,3,4-tricarboxylic acid
  • A115670
    cis-ACPD
    477331-06-9
    C₇H₁₁NO₄
    (±)-1-Aminocyclopentane-cis-1,3-dicarboxylic Acid; rel-(1R,3R)-1-Amino-1,3-cyclopentanedicarboxylic Acid
  • A115673
    trans-ACPD
    67684-64-4
    C₇H₁₁NO₄
    (±)-1-Aminocyclopentane-trans-1,3-dicarboxylic Acid; rel-(1R,3S)-1-Amino-1,3-cyclopentanedicarboxylic Acid; (±)-1-Aminocyclopentane-trans-1,3-dicarboxylic Acid; (±)-cis-1-Amino-1,3-dicarboxycyclopentane; (±)-trans-1-Amino-1,3-dicarboxycyclopentane; (±)-trans-1-Aminocyclopentyl-1,3-dicarboxylic Acid; (±)-trans-ACPD; 1-Amino-trans-1,3-cyclopentanedicarboxylic Acid; 1-Amino-trans-1,3-dicarboxycyclopentane; DL-cis-1-Amino-1,3-dicarboxycyclopentane; NSC 27386; Trans-(±)-ACPD; cis-1-Amino-1,3-dicarboxycyclopentane; trans-(±)-1-Amino-1,3-cyclopentanedicarboxylic Acid; trans-1-Amino-1,3-cyclopentanedicarboxylic Acid
  • A115675
    Ac-Phe-NH2
    7376-90-1
    C₁₁H₁₄N₂O₂
  • A115678
    Ac-Phe-Phe-OH
    10030-31-6
    C₂₀H₂₂N₂O₄
  • A117100
    2-amino-1-(4-methylphenyl)-1-Propanone Hydrochloride
    6941-17-9
    31952-47-3
    C₁₀H₁₃NO • HCl
    Nor-mephedrone HCl
  • A120000
    Acamprosate Calcium
    77337-73-6
    77337-76-9 free acid
    C₁₀H₂₀CaN₂O₈S₂
    3-(Acetylamino)-1-propanesulfonic Acid Calcium Salt; Alcomed; Aotal; Ca-AOTA; Calcium N-Acetylhomotaurinate; Calcium Acamprosate; Calcium Bisacetyl Homotaurine; Campral EC; Sobriol;
Translate »